IP Library Granted Patent US 7,858,097
Granted Patent B2
US 7,858,097 · App. 11/818,965 · Granted Dec 28, 2010

Antibiotic resistance free

Assignee: The Trustees of the University of Pennsylvania
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,858,097
App. No.
11/818,965
Granted
Dec 28, 2010
Kind
B2
Abstract

The present invention provides Listeria strains that express a heterologous antigen and a metabolic enzyme, and methods of generating same.

Claims (12)

1. A method of inducing an immune response against a protein antigen of interest in a subject, comprising the step of administering to said subject a recombinant Listeria strain, comprising an integrated nucleic acid molecule, wherein said integrated nucleic acid molecule does not comprise an antibiotic resistance gene, wherein said integrated nucleic acid molecule comprises a first open reading frame encoding a polypeptide and a second open reading frame encoding a metabolic enzyme, wherein said polypeptide comprises said protein antigen of interest, and wherein said metabolic enzyme complements a metabolic deficiency of said recombinant Listeria strain, thereby inducing an immune response against a protein antigen of interest in a subject.

2. The method of claim 1 , wherein said integrated nucleic acid molecule further comprises a gene encoding a transcription factor.

3. The method of claim 2 , wherein said gene encoding a transcription factor is lacking in the remainder of the chromosome of said recombinant Listeria strain.

4. The method of claim 1 , whereby said integrated nucleic acid molecule does not contain a replication region that functions in said recombinant Listeria strain.

5. The method of claim 1 , wherein said polypeptide is a fusion protein comprising said protein antigen and an additional polypeptide, wherein said additional peptide enhances the immunogenicity of said protein antigen.

6. The method of claim 5 , wherein said additional polypeptide is a non-hemolytic LLO protein or fragment thereof, a PEST amino acid sequence, or an ActA fragment.

7. The method of claim 1 , wherein said integrated nucleic acid molecule is a phage integration vector.

8. The method of claim 1 , wherein said metabolic enzyme is an amino acid metabolism enzyme.

9. The method of claim 1 , wherein said metabolic enzyme catalyzes a formation of an amino acid used for a cell wall synthesis in said recombinant Listeria strain.

10. The method of claim 1 , wherein said metabolic enzyme is an alanine racemase enzyme.

11. The method of claim 1 , wherein said metabolic enzyme is a D-amino acid transferase enzyme.

12. The method of claim 1 , wherein said recombinant Listeria strain has been passaged through an animal host.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2009
From: PATERSON, YVONNE; VERCH, THORSTEN
To: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Reel/Frame 022564/0552 →
Continuity (3)
Continuation In Part 1120341500 · Aug 15, 2005
Provisional Application 6060149200 · Aug 13, 2004
Related Publication 20100291140A1 · Nov 18, 2010